Javascript is disabled

Welcome to European Islet Study Group 2025


The European Islet Study Group is a conference for Islet biology in diabetes research. Organised yearly since 1991, EISG gathers the leading european and international islet researchers in the field of diabetes. 

The EISG conference is hosted by the Lund University Diabetes Centre, and will take place in Malmö in June 11-13, 2025.

The objective of EISG is to facilitate the exchange and development of ideas that might push forward groundbreaking research related to diabetes diagnosis, pathology, and treatment, and the role that islet cells play in the disease. 

There will also be a debate on "Are alpha cells and glucagon needed for islet function and glucose homoeostasis?".

The program includes invited speakers from all over the world. Our confirmed invited speakers (5 Swedish, 23 foreign) come from the United States, France, Denmark, United Kingdom, Sweden, Belgium, Germany, Finland, Israel, Switzerland, Slovenia, and Spain. 

The topics include:

•Genomic of islet cells
•Metabolism in islet cells
•The islet cell in Type 2 diabetes an treatment strategies
•The islet cell in Type 1 diabetes and treatment strategies
•Modelling human islet cell development
•Signaling and crosstalk in the islet  
•Debate: “Are alpha cells and glucagon needed for ilset function and glucose homeostasis?”
•Beta & non-beta cells

Host                                                           
Lund University Diabetes Centre            

Lund University Diabetes Centre is a vibrant research environment at Lund University with the long-term goal of preventing and curing diabetes, as well as improving the treatment of the disease and its complications. treatment of the disease and its complications. At LUDC, over 300 people conduct cutting-edge diabetes research spanning basic, molecular and genomic mechanisms to studies of people's lifestyles, diets and genetic predisposition of disease, as well as carrying out clinical trials.

LUDC conducts advanced research in islet biology, addressing fundamental aspects of both type 1 and type 2 diabetes. This includes in-depth studies of islet cell exocytosis and physiology to understand the precise cellular mechanisms that regulate hormone secretion. Metabolic pathways within islet cells and autoimmune responses are examined as are the genomic and epigenetic landscapes of islet cells, allowing identification of genetic determinants and molecular signatures underpinning diabetes. These cutting-edge studies aim to unravel complex biological processes, paving the way for novel therapeutic strategies and a potential cure for diabetes.

For more information, visit our website at: www.ludc.lu.se